NCT05367219

Brief Summary

The purpose of this project is to study the composition, hazard, and protection of smoke from endoscopic gastrointestinal surgery. The study is a single-center, prospective, randomized, controlled, cohort study. The investigators plan to enroll 80 patients who undergo endoscopic gastrointestinal surgery and 10 medical staff participating in surgery in the gastrointestinal endoscopy room of the First Affiliated Hospital of Xi'an Jiao Tong University. The investigators will randomize the included study subjects. The investigators will monitore smoke and try to remove the smoke with an air sterilizer in the Air sterilizer group. The control group was monitored for smoke without any intervention. The primary endpoint is concentration of PM2.5 in smoke from endoscopic gastrointestinal surgery, the risk factors, and the effect of air sterilizer on its removal. The secondary endpoint is the concentration of PM1.0, PM10, formaldehyde, Total Volatile Organic Compounds, CO, and CO2 in smoke from endoscopic gastrointestinal surgery, the risk factors, and the effect of air sterilizer on its removal. Other exploratory objectives include the hazards of smoke to staff in the gastrointestinal endoscopy room, and the viral content of smoke.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 10, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 5, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

August 5, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

April 24, 2022

Last Update Submit

August 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • PM2.5 in smoke from endoscopic gastrointestinal surgery

    Concentration of PM2.5 in smoke from endoscopic gastrointestinal surgery will be used by air quality testing equipment. The investigators will analyze the risk factors of PM2.5 related to surgery. The effect of air sterilizer on PM 2.5 removal will also be explored.

    During the surgery.

Secondary Outcomes (1)

  • Some other harmful substances in smoke from endoscopic gastrointestinal surgery.

    During the surgery.

Other Outcomes (2)

  • Hazards of smoke to staff in the gastrointestinal endoscopy room

    During the surgery and 24 hours after the surgery.

  • Viral quantitative of smoke from endoscopic gastrointestinal surgery

    40 minutes after surgery.

Study Arms (2)

Air sterilizer

EXPERIMENTAL

The invesitigators will monitore smoke and try to remove the smoke with an air sterilizer during the endoscopic gastrointestinal surgery in the experimental group.

Device: Air sterilizer

Control

NO INTERVENTION

The control group was monitored for smoke during the endoscopic gastrointestinal surgery without any intervention.

Interventions

The invesitigators will try to remove the smoke with an air sterilizer during the endoscopic gastrointestinal surgery in the Air sterilizer group.

Air sterilizer

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who undergo endoscopic gastrointestinal surgery and medical staff who participate in the surgery in the gastrointestinal endoscopy operating room of the First Affiliated Hospital of Xi'an Jiao Tong University
  • Voluntary participation in this study

You may not qualify if:

  • Severe liver disease
  • Severe Kidney disease
  • Severe cardiovascular disease
  • Severe cerebrovascular disease
  • Severe neuropsychiatric disease
  • Unable to cooperate with the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Shuixiang He

    First Affiliated Hospital of Xian Jiaotong University

    STUDY DIRECTOR

Central Study Contacts

Yun Feng, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2022

First Posted

May 10, 2022

Study Start

August 5, 2022

Primary Completion

October 31, 2022

Study Completion

November 30, 2022

Last Updated

August 5, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

The invesitigators will conduct further research on endoscopic surgical smoke